Effects of administration of captopril, metoprolol, and the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction-Reference-Cited by-同舟云学术

Effects of administration of captopril, metoprolol, and the captopril-metoprolol combination as adjuvant therapy during thrombolysis in acute myocardial infarction

Published:1994-12 Issue:6 Volume:8 Page:875-876
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Di Pasquale Pietro,Paterna Salvatore,Bucca Vincenzo,Licata Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00877407.pdf

Reference11 articles.

1. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus differed beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: Results of the Thrombolysis In Myocardial Infarction (TIMI II B) study.Circulation 1991;83:422?437.

2. The MIAMI trial research group. Metoprolol In Acute Myocardial Infarction (MIAMI): A randomized placebo-controlled international trial.Eur Heart J 1985;6:199?205.

3. ISIS 1 (First International Study of Infarct Survival) collaborative group. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS 1.Lancet 1986;2:57?62.

4. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction.N Engl J Med 1988;319:80?86.

5. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial (on behalf of the SAVE investigators).N Engl J Med 1992;327:669?677.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Captopril;Drugs & Aging;1995